+

PE20021100A1 - Compuestos de isoxazolona como inhibidores de citoquinas - Google Patents

Compuestos de isoxazolona como inhibidores de citoquinas

Info

Publication number
PE20021100A1
PE20021100A1 PE2002000440A PE2002000440A PE20021100A1 PE 20021100 A1 PE20021100 A1 PE 20021100A1 PE 2002000440 A PE2002000440 A PE 2002000440A PE 2002000440 A PE2002000440 A PE 2002000440A PE 20021100 A1 PE20021100 A1 PE 20021100A1
Authority
PE
Peru
Prior art keywords
alkinyl
alkenyl
alkyl
isoxazolone
cytokine inhibitors
Prior art date
Application number
PE2002000440A
Other languages
English (en)
Inventor
Michael Philip Clark
Biswanath De
Joshua Spector Tullis
Steven Karl Laughlin
Michael George Natchus
Jane Far-Jine Djung
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20021100A1 publication Critical patent/PE20021100A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERA A UN COMPUESTO DE ISOXAZOLONA DE FORMULA I DONDE CADA R1 ES ALQUILO, ALQUENILO, ALQUINILO, HETEROALQUILO, ENTRE OTROS; m ES 0-5; Q ES EL GRUPO a, b; R2 ES H, ALQUILO, ALQUENILO, ALQUINILO, HETEROALQUILO, HETEROALQUENILO, ENTRE OTROS; R3 ES H, ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS; X ES CR3, N; Y ES CR2, N; Y ES CR2, N; Z ES NR4, O, S; A ES C(O), N-G-; B ES C(O), N-G; SIEMPRE QUE UNO Y SOLAMENTE UNO DE A O B ES C(O); G ES H, ALQUILO, ALQUENILO, ALQUINILO, CICLOALQUILO, CICLOALQUENILO, ENTRE OTROS; R4 ES H, ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS; R5 ES H, ALQUILO, ALQUENILO, ALQUINILO, CICLOALQUILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS DE 2-ETOXIMETIL-4-(4-FLUOROFENIL)-3-PIRIDIN-4-IL-2H-ISOXAZOL-5-ONA, 4-(4-FLUOROFENIL)-2-METIL-3-PIRIDIN-4-IL-2H-ISOXAZOL-5-ONA, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LAS CITOQUINAS Y SON UTILES EN EL TRATAMIENTO DE ARTRITIS, OSTEOARTRITIS, DIABETES
PE2002000440A 2001-05-24 2002-05-24 Compuestos de isoxazolona como inhibidores de citoquinas PE20021100A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29388901P 2001-05-24 2001-05-24

Publications (1)

Publication Number Publication Date
PE20021100A1 true PE20021100A1 (es) 2003-02-19

Family

ID=23130995

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000440A PE20021100A1 (es) 2001-05-24 2002-05-24 Compuestos de isoxazolona como inhibidores de citoquinas

Country Status (6)

Country Link
US (2) US6790846B2 (es)
EP (1) EP1392299A1 (es)
CN (1) CN1511034A (es)
CA (1) CA2446801A1 (es)
PE (1) PE20021100A1 (es)
WO (1) WO2002094266A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589997B2 (en) * 2001-06-29 2003-07-08 North Shore-Long Island Jewish Health System Small-molecule modulators of hepatocyte growth factor/scatter factor activities
BR112015022162A2 (pt) 2014-09-16 2017-07-18 Procter & Gamble sonda fluorescente de zinco
BR112017024618B1 (pt) 2015-05-20 2023-03-14 Amgen Inc Compostos agonistas de triazol do receptor apj, composições e usos relacionados
US9988369B2 (en) 2016-05-03 2018-06-05 Amgen Inc. Heterocyclic triazole compounds as agonists of the APJ receptor
EP3541792B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole furan compounds as agonists of the apj receptor
EP3541805B1 (en) 2016-11-16 2020-10-14 Amgen Inc. Heteroaryl-substituted triazoles as apj receptor agonists
US10906890B2 (en) 2016-11-16 2021-02-02 Amgen Inc. Triazole phenyl compounds as agonists of the APJ receptor
US11191762B2 (en) 2016-11-16 2021-12-07 Amgen Inc. Alkyl substituted triazole compounds as agonists of the APJ Receptor
MA46827A (fr) 2016-11-16 2019-09-25 Amgen Inc Composés de triazole à substitution cycloalkyle en tant qu'agonistes du récepteur apj
WO2018093580A1 (en) 2016-11-16 2018-05-24 Amgen Inc. Triazole pyridyl compounds as agonists of the apj receptor
MA50509A (fr) 2017-11-03 2021-06-02 Amgen Inc Agonistes de triazole fusionnés du récepteur apj
EP3788037A1 (en) 2018-05-01 2021-03-10 Amgen Inc. Substituted pyrimidinones as agonists of the apj receptor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104369A0 (en) 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
DE69433501T2 (de) 1993-11-08 2004-11-04 Smithkline Beecham Corp. Oxazole zur behandlung von zytokinvermittelten erkrankungen
ATE294174T1 (de) 1996-06-10 2005-05-15 Merck & Co Inc Substituierte imidazole mit cytokinin- inhibirender wirkung
US5776954A (en) 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
WO1999003837A1 (en) 1997-06-30 1999-01-28 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
ATE266399T1 (de) 1998-08-20 2004-05-15 Smithkline Beecham Corp Neue substituierte triazolverbindungen
AU6476599A (en) 1998-11-03 2000-05-22 Novartis Ag Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles
CN1222520C (zh) 1999-08-12 2005-10-12 沃泰克斯药物股份有限公司 c－JUN N－末端激酶(JNK)和其它蛋白激酶的抑制剂

Also Published As

Publication number Publication date
EP1392299A1 (en) 2004-03-03
US6919346B2 (en) 2005-07-19
US6790846B2 (en) 2004-09-14
US20030096814A1 (en) 2003-05-22
CN1511034A (zh) 2004-07-07
WO2002094266A1 (en) 2002-11-28
CA2446801A1 (en) 2002-11-28
US20040122025A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
PE20021100A1 (es) Compuestos de isoxazolona como inhibidores de citoquinas
PE20020961A1 (es) Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
ECSP067013A (es) 2-quinolil-oxazoles sustituidos útiles como inhibidores de pde4
PE20211911A1 (es) Compuestos heterociclicos como inmunomoduladores
PE20021089A1 (es) Compuestos de triazol como inhibidores de las citoquinas
AR038717A1 (es) Ciclopropil-azol-carboxamidas
PE20091158A1 (es) 5-anilinoimidazopiridinas y metodos de uso
PE20090775A1 (es) Nuevos derivados de biarilo
ECSP066298A (es) Compuestos 1h-pirazol 3,4-disustituidos y su uso como moduladores de quinasas dependientes de ciclina (cdk) y quinasa-3 de sintasa de glicógeno (gsk-3)
PE20090238A1 (es) Derivados de pirazol como inhibidores de tirosinquinasas
PE20080611A1 (es) Compuestos de azabenzofuranil y metodos de uso
AR023152A1 (es) Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion
AR038240A1 (es) Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion
PE20030010A1 (es) Triazolopiridinas como inhibidores de quinasas
AR058403A1 (es) PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF.
PE20131197A1 (es) Compuestos de pirazolopirimidina como inhibidores de jak y composiciones farmaceuticas que los contienen
RS52313B (en) MYTHOSIS PROGRESS INHIBITION UNITS
PE20020786A1 (es) Derivados de azaindol antiviral
AR050267A1 (es) Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa
AR042668A1 (es) Derivados de fosfonoxi quinazolinas y su uso farmaceutico
SE0202133D0 (sv) Novel compounds
PE20070051A1 (es) Serin-amidas sustituidas con heteroaroilo
PE20120693A1 (es) Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
PE20151764A1 (es) Derivados de pirrolo[2,3-d]pirimidina
CO6160312A2 (es) Derivados de quiniclidina de acido (hetero) arilcicloheptano carboxilico como antagonistas del receptor muscarinico

Legal Events

Date Code Title Description
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载